Clinical trials registration
2006
GSK's Commitment to Clinical Trial Transparency
Commentary
Author Information
Author(s): Frank W. Rockhold, Ronald L. Krall
Primary Institution: GlaxoSmithKline
Conclusion
GSK emphasizes the importance of registering clinical trial results to enhance transparency and improve patient care.
Supporting Evidence
- GSK was the first company to establish a publicly available clinical trial register.
- The register currently has over 2,000 records of GSK-sponsored clinical trials.
- Industry made a commitment to disclose clinical trial information in January 2005.
Takeaway
GSK wants everyone to know about their clinical trials and the results, so doctors and patients can make better decisions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website